MYCN and neoplasm: PW-12 treated tumors demonstrate a significant decrease in MYCN protein expression and in tumor mass (p < 0.05) when compared to vehicle treated controls (Figures 2A,B), consistent with direct blockade of MYCN and subsequent anti-tumor effects.